Dr. Lei Stanley Qi is an Assistant Professor of Bioengineering at Stanford University, with a joint appointment in the Department of Chemical and Systems Biology, and a faculty fellow in ChEM-H. He has pioneered the development of the CRISPR/Cas technology for targeted genome engineering in mammalian cells. His work has lead to a series of gene regulation and imaging technologies, including CRISPR interference (CRISPRi), CRISPR imaging, and high-throughput CRISPR screening. He also worked in the fields of Synthetic Biology, and developed methods to generate synthetic noncoding RNA regulators of transcription, translation, and as molecular sensor for chemicals and intracellular proteins. He obtained his Ph.D. in Bioengineering from the University of California, Berkeley in 2012, and performed independent research as a Systems Biology Fellow in the University of California, San Francisco in 2012 to 2014. His lab is currently applying genome engineering and CRISPR technologies for the interrogation of genetic interaction networks related to cell differentiation, proliferation, epigenetic regulation and diseases.